✦ LIBER ✦

Long-term subjective functional outcome of surgery plus postoperative radiotherapy for advanced stage oral cavity and oropharyngeal carcinoma

✍ Scribed by Michael J. Zelefsky; Jeffrey Gaynor; Dennis Kraus; Elliot W. Strong; Jatin P. Shah; Louis B. Harrison

Book ID: 117026519
Publisher: Elsevier Science
Year: 1996
Tongue: English
Weight: 577 KB
Volume: 171
Category: Article
ISSN: 0002-9610
DOI: 10.1016/s0002-9610(97)89563-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term treatment results of postopera

Long-term treatment results of postoperative radiation therapy for advanced stage oropharyngeal carcinoma

✍ Michael J. Zelefsky; Louis B. Harrison; John G. Armstrong 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 722 KB

Long-term quality of life after treatmen

Long-term quality of life after treatment for locally advanced oropharyngeal carcinoma: Surgery and postoperative radiotherapy versus concurrent chemoradiation

✍ Paolo Boscolo-Rizzo; Marco Stellin; Roberto Fuson; Carlo Marchiori; Alessandro G 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 138 KB

Preoperative concurrent chemoradiotherap

Preoperative concurrent chemoradiotherapy plus radical surgery for advanced squamous cell carcinoma of the oral cavity: an analysis of long-term results

✍ T Kirita; K Ohgi; H Shimooka; Y Yamanaka; S Tatebayashi; K Yamamoto; K Mishima; 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 194 KB

A randomized trial of long term adjuvant

A randomized trial of long term adjuvant tamoxifen plus postoperative radiation therapy versus radiation therapy alone for patients with early stage breast carcinoma treated with breast-conserving surgery

✍ Kristina Dalberg; Hemming Johansson; Ulla Johansson; Lars E. Rutqvist 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB 👁 2 views

## BACKGROUND. The use of adjuvant tamoxifen to treat postmenopausal breast carcinoma patients as an adjunct to primary surgery is well established. The current study reports the long term results for a low risk stratum in a randomized trial of adjuvant tamoxifen. The main focus of this analysis w